| scholarly article | Q13442814 |
| P50 | author | Dixon B Kaufman | Q57010144 |
| Arjang Djamali | Q88438849 | ||
| Didier A Mandelbrot | Q88724038 | ||
| Robert R Redfield III | Q90922948 | ||
| P2093 | author name string | Brad C Astor | |
| Joseph R Scalea | |||
| Weixiong Zhong | |||
| Thomas M Ellis | |||
| Millie Samaniego | |||
| Tiffany J Zens | |||
| Sarah Panzer | |||
| Brenda L Muth | |||
| P433 | issue | 4 | |
| P304 | page(s) | 346-352 | |
| P577 | publication date | 2016-02-08 | |
| P1433 | published in | Human Immunology | Q15709955 |
| P1476 | title | Current outcomes of chronic active antibody mediated rejection - A large single center retrospective review using the updated BANFF 2013 criteria | |
| P478 | volume | 77 |
| Q39130806 | A systematic review of the use of rituximab for the treatment of antibody-mediated renal transplant rejection. |
| Q92322383 | An in vitro model of antibody-mediated injury to glomerular endothelial cells: Upregulation of MHC class II and adhesion molecules |
| Q37698860 | Antibody-Mediated Rejection: A Review |
| Q91251184 | Antibody-mediated rejection in the Banff classifications of 2007 and 2017: A comparison of renal graft loss prediction capability |
| Q53504304 | Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients. |
| Q39009557 | Chronic allograft injury: Mechanisms and potential treatment targets |
| Q92803508 | Donor-Specific Antibodies in the Absence of Rejection Are Not a Risk Factor for Allograft Failure |
| Q47286616 | Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated Rejection. |
| Q55413815 | Fatal Pneumococcus Sepsis after Treatment of Late Antibody-Mediated Kidney Graft Rejection. |
| Q64226624 | Glomerular C3 Deposition Is an Independent Risk Factor for Allograft Failure in Kidney Transplant Recipients With Transplant Glomerulopathy |
| Q51157126 | Graft Immunocomplex Capture Fluorescence Analysis to Detect Donor-Specific Antibodies and HLA Antigen Complexes in the Allograft. |
| Q47876027 | Morphologic patterns and treatment of transplant glomerulopathy: A retrospective analysis |
| Q52373361 | Reflections on the usefulness of extracorporeal photopheresis in renal transplant rejection: A concise review of the involved mechanisms and therapeutic perspectives. |
| Q52656964 | Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation. |
| Q57474736 | Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection |
| Q92469286 | Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial |
| Q92899718 | The therapeutic challenge of late antibody-mediated kidney allograft rejection |
| Q92450432 | Treatment of chronic active antibody-mediated rejection in renal transplant recipients - a single center retrospective study |
| Q47920746 | Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial. |
| Q65000602 | Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection. |
| Q58754949 | Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results |
Search more.